JNJ — Johnson & Johnson Share News
0.000.00%
Last trade - 00:00- $610.38bn
- $638.66bn
- $94.19bn
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Brief: Johnson & Johnson Announces New Data For Tremfya
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived
Health Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin
Healthcare stocks rally as investors seek safety amid tech debt worries
US RESEARCH ROUNDUP-BlackRock, Microsoft, TransDigm Group
Street View: J&J's macro troubles to pass, brokerages say
US RESEARCH ROUNDUP-Adobe, Domino's Pizza, Goldman Sachs
Live Markets: US stocks finish down with bank shares
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
US STOCKS ON THE MOVE-Bumble, Cardinal Infrastructure, Qualcomm, Grail
Johnson & Johnson eyes biggest drop in over 18 months on weak device sales
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
US STOCKS ON THE MOVE-Albertsons, Johnson & Johnson, UnitedHealth
Medical device makers slip in sympathy with J&J's MedTech miss
Johnson & Johnson slips as weak device sales clouds earnings beat
Johnson & Johnson reports results for the quarter ended September 30 - Earnings Summary
US STOCKS ON THE MOVE-Humana, Symbotic, JPMorgan, Visa
US STOCKS ON THE MOVE-Johnson & Johnson, JPMorgan, UnitedHealth, Goldman Sachs